Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Aspects of Healthcare that Have Evolved for Good in the Wake of COVID

Although many people are hoping for things to return to normal after the pandemic is over, the healthcare industry is one area that won’t look the same in a post-pandemic world. In a matter of weeks, the entire industry was upended in an attempt to save the lives of those affected by the coronavirus –…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
Aspects of Healthcare that Have Evolved for Good in the Wake of COVID

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Although many people are hoping for things to return to normal after the pandemic is over, the healthcare industry is one area that won’t look the same in a post-pandemic world. In a matter of weeks, the entire industry was upended in an attempt to save the lives of those affected by the coronavirus – and the ripples of these changes will affect the industry for years to come.

Here, we’ll look at three aspects of healthcare that have been transformed by the COVID-19 pandemic.

Trend #1: A Greater Emphasis on Patient-Focused Care

Before the pandemic, receiving care was a process that often took longer than necessary, with administrative bottlenecks and wait times at an all-time high.

However, because of the coronavirus crisis, healthcare leaders are understanding the importance of people receiving care when they need it. After all, any lack in urgency could easily cost someone their life.

The focus on healthcare is slowly transitioning to a patient-focused model, where care and overall service revolves around the care receiver rather than the provider. As a result, features like easily accessible electronic forms and prescription delivery services encourage patients to get more involved with their care and improve their overall experience.

Trend #2: Elevated Telehealth and Remote Patient Monitoring

Not long ago, telehealth was seen as inferior to in-person care and a last resort option for many patients. Nowadays, it’s essential to the health and safety of both patients and care providers.

Because telehealth doctors don’t have the same logistical restraints that in-person providers have, patients can often secure telehealth appointments much sooner. They can also be treated wherever they are without risking infection from others, especially if they’re immunocompromised.

On the other hand, those who do have COVID can be treated while limiting the risk of exposure to those around them.

Trend #3: Increased In-Home Care for the Elderly

Many families feel uneasy about bringing their relatives to a nursing home, in part because of the lack of transparency around the care they receive. However, the pandemic has highlighted another reason to reconsider the idea.

New York Times article revealed that 34% of all American COVID deaths at the time of writing – a staggering 152,000 – were linked to nursing homes. A crowd of people living together in a cramped space makes it easier for diseases to spread, and weakened immune systems result in more deaths.

Although sickness is an inevitable part of life, families are now choosing to reduce the risk by keeping their relatives close to home. Others even have their loved ones move in with them. Additionally, they may decide to hire in-home medical help to ensure that their relatives get the best level of care possible.

Champion: Medical Seating Designed with Evolution in Mind

With the standards of healthcare changing right before our eyes, your patients deserve a level of care that can adapt just as quickly.

Champion has developed medical chairs that can be used in a variety of settings, from acute care, emergent procedures and multipurpose patient needs to in-home treatment. Their versatility allows providers to administer care in a variety of settings, while their user-centric design improves the level of comfort of the patients that use them.

To learn more about Champion’s products and the benefits they offer, visit www.championchair.com/applications.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Interchangeable biosimilars are getting approved faster, and Wezlana shows why

Interchangeable biosimilars are getting approved faster, and Wezlana shows why

The FDA approved Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara for multiple inflammatory diseases, which means it may be substituted without consulting the prescriber, subject to state pharmacy laws. A Springer analysis reported 26 interchangeable biosimilars approved since 2020 and said average approval timelines decreased from 798 days for applications dated in 2020 to 364 days for applications dated in 2024. The operational pressure shifts to formulary, payer, and specialty pharmacy workflow design.

  • 01Interchangeability is becoming the default ask, not an afterthought: Springer found 17 of 26 approvals pursued interchangeability concurrently, which changes how buyers should time contracting and conversions.
  • 02Springer reported average approval timelines decreased from 798 days for applications dated in 2020 to 364 days for applications dated in 2024, which can compress planning windows for monitoring and implementation.
  • 03A new interchangeable ustekinumab option means the hard work is no longer clinical, it is operational: NDC mapping, EMR preference lists, substitution rules by state, and patient communications decide whether savings show up.

Sep 8, 2026

AAO-HNSF hearing loss guideline moves audiograms and amplification into primary care

AAO-HNSF’s new age-related hearing loss guideline calls for screening adults starting at age 50 and escalating to otoscopy, audiogram, and appropriately fit amplification. It shifts hearing loss from “patient complaint” to a routine primary-care workflow. The pressure shows up in audiology capacity, referral design, and documentation standards.

  • 01Screening at age 50 becomes a repeatable workflow, so capacity planning shifts from episodic ENT referrals to steady primary-care volume, especially where annual wellness visits are a dominant access point.
  • 02The guideline’s escalation sequence, screen, otoscopy, audiogram, amplification, then cochlear implant candidacy evaluation, creates a measurable funnel that health systems can instrument in the EHR and manage like any other pathway.
  • 03Asymmetric loss remains a separate trigger for MRI in many settings, and 2026 pre-proof work using NHANES and SEER highlights why imaging criteria choices can swing scan volume, a budgeting and radiology access issue, not a clinical footnote.

Sep 7, 2026

ADHA shifts My Health Record to multi-supplier ops as Accenture signs new 3-year contract

ADHA shifts My Health Record to multi-supplier ops as Accenture signs new 3-year contract

Accenture will keep supporting Australia’s My Health Record under a new three-year contract. ADHA is moving the platform to a multi-supplier operating model. The shift raises questions about shared integration discipline, tooling, and accountability when changes hit production.

  • 01Multi-supplier delivery is spreading across national-scale health platforms, as ADHA's My Health Record shift shows, moving risk from vendor selection to integration, runbooks, and accountability.
  • 02GenAI model upgrades are arriving with healthcare-specific claims, but the procurement work moves to evidence, safety controls, and monitoring once models sit inside clinical workflows.
  • 03Embedded AI expands the cyber asset inventory problem: if teams cannot discover the AI components across endpoints and devices, they cannot reliably secure or audit them.

Sep 7, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512